Triple
T36599501
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | fam-trastuzumab deruxtecan |
E902880
|
entity |
| Predicate | instanceOf |
P0
|
FINISHED |
| Object | antibody–drug conjugate |
C27668
|
CONCEPT FINISHED |
How this triple was built (1 step)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
CD
Concept disambiguation
gpt-5-mini-2025-08-07
Target class: antibody–drug conjugate Context triple: [fam-trastuzumab deruxtecan, instanceOf, antibody–drug conjugate]
-
A.
monoclonal antibody
A monoclonal antibody is a laboratory-produced molecule engineered to bind specifically to a single epitope on an antigen, enabling targeted detection or treatment of diseases.
-
B.
antineoplastic immunomodulating agent
chosen
An antineoplastic immunomodulating agent is a drug that treats cancer by modifying or enhancing the body’s immune response to recognize and destroy malignant cells.
-
C.
anti‑cancer drug
An anti-cancer drug is a pharmacological agent designed to prevent, inhibit, or eliminate the growth and spread of malignant cells in the body.
-
D.
cancer drug
A cancer drug is a therapeutic agent specifically designed to prevent, slow, or eliminate the growth and spread of cancer cells in the body.
-
E.
nitrogen mustard derivative
A nitrogen mustard derivative is a chemical compound structurally related to nitrogen mustards, typically designed to act as an alkylating agent that can modify DNA or other biomolecules, often used in chemotherapy or as a research tool.
- F. None of above.
Provenance (1 batch)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69f76e66b7b88190848f7a3e1188915f |
completed | May 3, 2026, 3:48 p.m. |
Created at: May 3, 2026, 4:11 p.m.